Agenus (AGEN) Operating Leases (2019 - 2026)
Agenus (AGEN) posted quarterly Operating Leases of $9.8 million for Q1 2026, down 81.8% year-over-year from $54.0 million in Q1 2025, and down 2.78% quarter-over-quarter from $10.1 million in Q4 2025.
Analysis
Agenus (AGEN) Operating Leases (2019 - 2026) Analysis & Trends
Agenus' Operating Leases history runs 8 years deep, the most recent figure standing at $9.8 million for Q1 2026.
- In Q1 2026, Operating Leases fell 81.8% year-over-year to $9.8 million; the TTM figure through Mar 2026 stood at $9.8 million (down 81.8% YoY), while the FY2025 annual figure was $10.1 million, down 81.47% from the prior year.
- Operating Leases for Q1 2026 stood at $9.8 million, down from $10.1 million in the prior quarter.
- The five-year high for Operating Leases was $64.6 million in Q2 2022, with the low at $9.8 million in Q1 2026.
- The 5-year median for Operating Leases is $55.8 million (2024), against an average of $50.3 million.
- The sharpest annual moves came in 2022 and 2026: Operating Leases soared 85.51% in 2022, then plunged 81.8% in 2026.
- Agenus' Operating Leases stood at $63.3 million in 2022, then dropped by 1.29% to $62.5 million in 2023, then dropped by 12.73% to $54.6 million in 2024, then slumped by 81.47% to $10.1 million in 2025, then dropped by 2.78% to $9.8 million in 2026.
- Business Quant data shows AGEN's Operating Leases at $9.8 million in Q1 2026, $10.1 million in Q4 2025, and $10.4 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Agenus | 342.07 Mn | 342.07 Mn | 34.52 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.54 Mn |
| Mar 31, 2026 | 9.83 Mn |
| Dec 31, 2025 | 10.11 Mn |
| Sep 30, 2025 | 10.38 Mn |
| Jun 30, 2025 | 53.39 Mn |
| Mar 31, 2025 | 53.98 Mn |
| Dec 31, 2024 | 54.55 Mn |
| Sep 30, 2024 | 55.16 Mn |
| Jun 30, 2024 | 55.79 Mn |
| Mar 31, 2024 | 61.76 Mn |
| Dec 31, 2023 | 62.51 Mn |
| Sep 30, 2023 | 63.17 Mn |
| Jun 30, 2023 | 62.25 Mn |
| Mar 31, 2023 | 62.86 Mn |
| Dec 31, 2022 | 63.33 Mn |
| Sep 30, 2022 | 63.82 Mn |
| Jun 30, 2022 | 64.57 Mn |
| Mar 31, 2022 | 47.42 Mn |
| Dec 31, 2021 | 42.11 Mn |
| Sep 30, 2021 | 38.90 Mn |